Nanwei Xu

机构：Changzhou No.2 People's Hospital, Changzhou Third People's Hospital · ORCID：0000-0001-6927-3312

发表论文 110 篇 · 总被引 2030 次 · h-index 24

代表论文

• Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage (2022 · Cellular & Molecular Biology Letters · 被引 117)
• Synergetic integrations of bone marrow stem cells and transforming growth factor‐β1 loaded chitosan nanoparticles blended silk fibroin injectable hydrogel to enhance repair and regeneration potential in articular cartilage tissue (2022 · International Wound Journal · 被引 55)
• Theaflavin‐3,3′‐Digallate Inhibits Erastin‐Induced Chondrocytes Ferroptosis via the Nrf2/GPX4 Signaling Pathway in Osteoarthritis (2022 · Oxidative Medicine and Cellular Longevity · 被引 47)
• Harmine Alleviates Titanium Particle-Induced Inflammatory Bone Destruction by Immunomodulatory Effect on the Macrophage Polarization and Subsequent Osteogenic Differentiation (2021 · Frontiers in Immunology · 被引 30)
• KLF4, negatively regulated by miR-7, suppresses osteoarthritis development via activating TGF-β1 signaling (2021 · International Immunopharmacology · 被引 27)
• Effect of pharmacist intervention on antibiotic prophylaxis in orthopedic internal fixation: A retrospective study (2022 · Research in Social and Administrative Pharmacy · 被引 12)